Supplementary Figure 2: EGFR is important for TEX-mediated suppression of innate antiviral immunity

(a) Plaque assay of VSV titers in the lungs (left) and HSV-1 titers in the brains (right) of mice treated as in Fig. 2d,b. (b) Plaque assay of VSV titers in the lungs (left) and HSV-1 titers in the brains (right) of mice treated as in Fig. 2d,e. (c) Percentage of pEGFR⁺ crExos beads in tumor-inoculated mice treated without (w/) or with Lapatinib (w/+Lapa.) and infected with HSV-1 as in Fig. 2d,e. Graphical representation of correlation between IFN-β secretion and pEGFR⁺ crExo levels in tumor-inoculated mice infected with HSV-1 as in Fig. 2e.